by Guest Contributer | Nov 9, 2021 | Drug & Alcohol Testing, Feature, Marijuana & CBD, Uncategorized
By Bill Current, founder of Current Consulting Group. Originally prepared for and published by PBSA in the Sept-Oct 2021 edition of the Journal. Read the full issue here. Which drug testing method—urine, oral fluid or hair—is best at detecting marijuana and...
by Guest Contributer | Mar 9, 2021 | Drug & Alcohol Testing, Feature
By Dr. William D. Brooks, American Association of Medical Review Officers (AAMRO), Founding Member, Past V.P., Trainer, Advisory Board Member GAC & Education Committee NDASA, OStG Today’s litigious marketplace requires all participants in a drug testing program to...
by NDASA | Feb 26, 2021 | Drug & Alcohol Testing, Feature, Industry News
At the end of 2020, the National Drug & Alcohol Screening Association introduced the NDASA Accreditation program for Collection Sites, Consortiums and Third-Party Administrators, Designated Employer Representatives and (coming soon) Substance Abuse Professionals....
by NDASA | Feb 4, 2021 | DOT, Drug & Alcohol Testing, Feature
Since the new 2020 U.S. Department of Transportation Custody and Control Form became available in September, one tiny addition has created a tremendous amount of confusion among employers, specimen collectors and others involved in DOT-mandated drug screening. The...
by Guest Contributer | Jan 27, 2021 | Drug & Alcohol Testing, Feature, Opioids
Thank you to NDASA member organization Psychemedics for sharing its January blog with our members. Psychemedics is a world leader in hair testing and a top innovator in the drug screening industry. For many, the turn of a new year is a time we resolve to reassess and...
by NDASA | Dec 2, 2020 | Drug & Alcohol Testing, Feature, Substance Use/Addiction
By Nadine Wentzell, NDASA member and owner of Nadine Wentzell Consulting, Inc., a workplace drug, alcohol and cannabis consultancy in Halifax, Nova Scotia. My primary role as a workplace drug, alcohol and cannabis consultant is to educate. One of the key areas of this...
by NDASA | Nov 23, 2020 | Drug & Alcohol Testing, Feature
Thank you to NDASA board member George Gilpatrick, a senior auditor and team leader for the Federal Transit Administration (FTA) Drug & Alcohol Compliance Auditing Program, for providing this valuable information during a recent NDASA Member’s Memo podcast....
by NDASA | Nov 3, 2020 | Drug & Alcohol Testing, Feature, Marijuana & CBD
By Chuck Marting, Colorado Mobile Testing , Impairment Detection Academy, Host of Clearing the Haze podcast. At the beginning of this third quarter I met with one of our clients who had been selected for a random DOT drug test. As we sat down, the driver who also...
by NDASA | Oct 3, 2020 | Drug & Alcohol Testing, Feature
By Lynn Riemer, president and founder of ACT on Drugs. a Colorado-based non-profit committed to raising awareness about the devastating lifestyle and physical effects of drug use and abuse. Those working in the drug and alcohol screening...
by NDASA | Sep 25, 2020 | Drug & Alcohol Testing, Feature, FMCSA
Nearly a year after the opening of the Federal Motor Carrier Safety Administration Drug & Alcohol Clearinghouse, NDASA members continue to report some confusion among their clients and business partners when it comes to the federally mandated national...